Harald Hampel
Department of Psychiatry
Geriatric Psychiatry Branch
Dementia Research Section
Ludwig-Maximilian University Munich
Germany
[email]@psy.med.uni-muenchen.de
Name/email consistency: high
- Pattern of interleukin-6 receptor complex immunoreactivity between cortical regions of rapid autopsy normal and Alzheimer's disease brain. Hampel, H., Haslinger, A., Scheloske, M., Padberg, F., Fischer, P., Unger, J., Teipel, S.J., Neumann, M., Rosenberg, C., Oshida, R., Hulette, C., Pongratz, D., Ewers, M., Kretzschmar, H.A., Möller, H.J. Eur. Arch. Psychiatry. Clin. Neurosci (2005)
- Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease: a comparative cerebrospinal fluid study. Hampel, H., Buerger, K., Zinkowski, R., Teipel, S.J., Goernitz, A., Andreasen, N., Sjoegren, M., DeBernardis, J., Kerkman, D., Ishiguro, K., Ohno, H., Vanmechelen, E., Vanderstichele, H., McCulloch, C., Moller, H.J., Davies, P., Blennow, K. Arch. Gen. Psychiatry (2004)
- Core biological marker candidates of Alzheimer's disease - perspectives for diagnosis, prediction of outcome and reflection of biological activity. Hampel, H., Mitchell, A., Blennow, K., Frank, R.A., Brettschneider, S., Weller, L., Möller, H.J. J. Neural. Transm (2004)
- Total and phosphorylated tau proteins: evaluation as core biomarker candidates in frontotemporal dementia. Hampel, H., Teipel, S.J. Dement. Geriatr. Cogn. Disord (2004)
- Advances in the development of biomarkers for Alzheimer's disease: from CSF total tau and Abeta(1-42) proteins to phosphorylated tau protein. Hampel, H., Goernitz, A., Buerger, K. Brain Res. Bull. (2003)
- Age transformation of combined hippocampus and amygdala volume improves diagnostic accuracy in Alzheimer's disease. Hampel, H., Teipel, S.J., Bayer, W., Alexander, G.E., Schwarz, R., Schapiro, M.B., Rapoport, S.I., Möller, H.J. J. Neurol. Sci. (2002)
- In vivo imaging of region and cell type specific neocortical neurodegeneration in Alzheimer's disease. Perspectives of MRI derived corpus callosum measurement for mapping disease progression and effects of therapy. Evidence from studies with MRI, EEG and PET. Hampel, H., Teipel, S.J., Alexander, G.E., Pogarell, O., Rapoport, S.I., Möller, H.J. J. Neural. Transm (2002)
- Severe hirsutism associated with psychopharmacological treatment in major depression. Hampel, H., Kötter, H.U., Padberg, F., Berger, C. World J. Biol. Psychiatry (2001)
- Corpus callosum measurement as an in vivo indicator for neocortical neuronal integrity, but not white matter pathology, in Alzheimer's disease. Hampel, H., Teipel, S.J., Alexander, G.E., Horwitz, B., Pietrini, P., Hippius, H., Möller, H.J., Schapiro, M.B., Rapoport, S.I. Ann. N. Y. Acad. Sci. (2000)
- Discriminant power of combined cerebrospinal fluid tau protein and of the soluble interleukin-6 receptor complex in the diagnosis of Alzheimer's disease. Hampel, H., Teipel, S.J., Padberg, F., Haslinger, A., Riemenschneider, M., Schwarz, M.J., Kötter, H.U., Scheloske, M., Buch, K., Stübner, S., Dukoff, R., Lasser, R., Müller, N., Sunderland, T., Rapoport, S.I., Möller, H.J. Brain Res. (1999)
- Corpus callosum atrophy is a possible indicator of region- and cell type-specific neuronal degeneration in Alzheimer disease: a magnetic resonance imaging analysis. Hampel, H., Teipel, S.J., Alexander, G.E., Horwitz, B., Teichberg, D., Schapiro, M.B., Rapoport, S.I. Arch. Neurol. (1998)
- Interleukin-6 is not altered in cerebrospinal fluid of first-degree relatives and patients with Alzheimer's disease. Hampel, H., Schoen, D., Schwarz, M.J., Kötter, H.U., Schneider, C., Sunderland, T., Dukoff, R., Levy, J., Padberg, F., Stübner, S., Buch, K., Müller, N., Möller, H.J. Neurosci. Lett. (1997)
- Detection of the novel cell adhesion molecule MUC18 in human brain tissue. Hampel, H., Körschenhausen, D.A., Schwarz, M.J., Frenzel, K.H., Johnson, J.P., Penning, R., Ackenheil, M., Müller, N. Neuroimmunomodulation (1997)
